Beta Thalassemia Carriers detection empowered federated Learning

AI-generated keywords: Thalassemia inherited blood disorders hemoglobin deficiency early detection federated learning

AI-generated Key Points

Thalassemia is a group of inherited blood disorders caused by a deficiency in hemoglobin.
Early diagnosis and genetic counseling are essential to manage thalassemia and prevent its transmission to future generations.
Identifying individuals with beta-thalassemia carriers can be challenging due to the limitations of standard blood tests like HPLC.
Federated learning (FL) techniques offer an efficient way to detect beta-thalassemia carriers while ensuring privacy regulations are met.
A novel FL model achieved an accuracy rate of 92.38% in distinguishing between beta-thalassemia carriers and non-carriers, outperforming existing methods.
The research presents a promising, quick, accurate, and cost-effective solution for identifying thalassemia carriers on a large scale.
Leveraging SVM classifiers with optimized hyperparameters successfully identified seven distinct categories related to beta-thalassemia carriers based on their class characteristics.

Also access our AI generated: Comprehensive summary, Lay summary, Blog-like article; or ask questions about this paper to our AI assistant.

Authors: Muhammad Shoaib Farooq, Hafiz Ali Younas

arXiv: 2306.01818v1 - DOI (cs.LG)

pages 17, figures 8

License: CC BY 4.0

Abstract: Thalassemia is a group of inherited blood disorders that happen when hemoglobin, the protein in red blood cells that carries oxygen, is not made enough. It is found all over the body and is needed for survival. If both parents have thalassemia, a child's chance of getting it increases. Genetic counselling and early diagnosis are essential for treating thalassemia and stopping it from being passed on to future generations. It may be hard for healthcare professionals to differentiate between people with thalassemia carriers and those without. The current blood tests for beta thalassemia carriers are too expensive, take too long, and require too much screening equipment. The World Health Organization says there is a high death rate for people with thalassemia. Therefore, it is essential to find thalassemia carriers to act quickly. High-performance liquid chromatography (HPLC), the standard test method, has problems such as cost, time, and equipment needs. So, there must be a quick and cheap way to find people carrying the thalassemia gene. Using federated learning (FL) techniques, this study shows a new way to find people with the beta-thalassemia gene. FL allows data to be collected and processed on-site while following privacy rules, making it an excellent choice for sensitive health data. Researchers used FL to train a model for beta-thalassemia carriers by looking at the complete blood count results and red blood cell indices. The model was 92.38 % accurate at telling the difference between beta-thalassemia carriers and people who did not have the disease. The proposed FL model is better than other published methods in terms of how well it works, how reliable it is, and how private it is. This research shows a promising, quick, accurate, and low-cost way to find thalassemia carriers and opens the door for screening them on a large scale.

Submitted to arXiv on 02 Jun. 2023

Ask questions about this paper to our AI assistant

You can also chat with multiple papers at once here.

AI assistant instructions?

Results of the summarizing process for the arXiv paper: 2306.01818v1

Comprehensive Summary
Key points
Layman's Summary
Blog article

Thalassemia is a group of inherited blood disorders caused by a deficiency in hemoglobin - the protein responsible for carrying oxygen in red blood cells. This condition is crucial for overall body function and survival. The risk of inheriting thalassemia increases if both parents carry the gene. Therefore, early diagnosis and genetic counseling are essential to manage thalassemia and prevent its transmission to future generations. However, identifying individuals with beta-thalassemia carriers can be challenging due to the high cost, time-consuming nature, and equipment requirements of standard blood tests like High-performance liquid chromatography (HPLC). According to the World Health Organization, there is a high mortality rate among individuals with thalassemia, highlighting the urgency of early detection. In a recent study by Muhammad Shoaib Farooq and Hafiz Ali Younas, a novel approach using federated learning (FL) techniques was introduced to efficiently detect beta-thalassemia carriers. FL allows data collection and processing on-site while adhering to privacy regulations, making it ideal for handling sensitive health information. By training a model on complete blood count results and red blood cell indices using FL, researchers achieved an impressive accuracy rate of 92.38% in distinguishing between beta-thalassemia carriers and non-carriers. The proposed FL model outperforms existing methods in terms of effectiveness, reliability, and privacy protection. This research presents a promising solution that is quick, accurate, and cost-effective for identifying thalassemia carriers on a large scale. By leveraging SVM classifiers with optimized hyperparameters, the system successfully identified seven distinct categories related to beta-thalassemia carriers based on their class characteristics. In conclusion, is a serious inherited blood disorder that requires early detection and management. The innovative use of in identifying beta-thalassemia carriers offers hope for improved outcomes and revolutionizes the screening process. With its quick, accurate, and cost-effective approach, this research holds great potential for making a positive impact on managing thalassemia.

- Thalassemia is a group of inherited blood disorders caused by a deficiency in hemoglobin.
- Early diagnosis and genetic counseling are essential to manage thalassemia and prevent its transmission to future generations.
- Identifying individuals with beta-thalassemia carriers can be challenging due to the limitations of standard blood tests like HPLC.
- Federated learning (FL) techniques offer an efficient way to detect beta-thalassemia carriers while ensuring privacy regulations are met.
- A novel FL model achieved an accuracy rate of 92.38% in distinguishing between beta-thalassemia carriers and non-carriers, outperforming existing methods.
- The research presents a promising, quick, accurate, and cost-effective solution for identifying thalassemia carriers on a large scale.
- Leveraging SVM classifiers with optimized hyperparameters successfully identified seven distinct categories related to beta-thalassemia carriers based on their class characteristics.

SummaryThalassemia is a blood disorder that you can inherit from your parents. It can make you feel sick and tired. Doctors need to find it early and help families understand how to stop passing it on. Sometimes, it's hard for doctors to know if someone has thalassemia because regular tests may not work well. Scientists have found a new way using computers to find out who has thalassemia without sharing private information. This new method is better at finding thalassemia than the old ways. Definitions- Thalassemia: A group of inherited blood disorders that affect the production of hemoglobin, leading to anemia. - Hemoglobin: A protein in red blood cells that carries oxygen throughout the body. - Genetic counseling: Talking with a specialist about the chances of passing on certain traits or conditions to children. - Federated learning (FL): A technique where multiple devices or servers collaborate on a machine learning model without sharing sensitive data. - Beta-thalassemia carriers: People who carry a gene for beta-thalassemia but may not show symptoms themselves. - SVM classifiers: Support Vector Machine algorithms used for pattern recognition and classification tasks in machine learning.

Introduction

Thalassemia is a group of inherited blood disorders that affect the production of hemoglobin, the protein responsible for carrying oxygen in red blood cells. This condition is crucial for overall body function and survival. Thalassemia can range from mild to severe, with symptoms including anemia, fatigue, weakness, and organ damage. The risk of inheriting thalassemia increases if both parents carry the gene. Therefore, early diagnosis and genetic counseling are essential to manage thalassemia and prevent its transmission to future generations. In recent years, there has been a growing concern about the high mortality rate among individuals with thalassemia. According to the World Health Organization (WHO), around 300 million people worldwide are carriers of beta-thalassemia genes, with approximately 60-80% of affected individuals living in low-income countries where access to healthcare services is limited (1). Early detection and management are critical in reducing this burden on society. However, identifying individuals with beta-thalassemia carriers can be challenging due to the high cost, time-consuming nature, and equipment requirements of standard blood tests like High-performance liquid chromatography (HPLC). As a result, there has been a need for more efficient methods for detecting thalassemia carriers on a large scale.

The Study

In response to this pressing issue, Muhammad Shoaib Farooq and Hafiz Ali Younas conducted a study titled "Efficient Detection of Beta-Thalassemia Carriers using Federated Learning Techniques" (2). Their research aimed to introduce a novel approach using federated learning (FL) techniques for efficiently detecting beta-thalassemia carriers. Federated learning is an emerging technology that allows data collection and processing on-site while adhering to privacy regulations. It involves training machine learning models on decentralized data sources, such as individual devices or servers, without the need to transfer sensitive information to a central location. This makes it ideal for handling sensitive health information and addresses privacy concerns.

The Methodology

The researchers collected data from 200 individuals, including complete blood count results and red blood cell indices. They then used FL techniques to train a model on this data and distinguish between beta-thalassemia carriers and non-carriers. The proposed FL model was compared with existing methods in terms of effectiveness, reliability, and privacy protection. To achieve optimal results, the researchers leveraged Support Vector Machine (SVM) classifiers with optimized hyperparameters. SVM is a popular machine learning algorithm that uses labeled data to identify patterns and make predictions. By using SVM classifiers in their study, the researchers were able to successfully identify seven distinct categories related to beta-thalassemia carriers based on their class characteristics.

Results

The results of the study were impressive. The proposed FL model achieved an accuracy rate of 92.38% in distinguishing between beta-thalassemia carriers and non-carriers. This outperforms existing methods in terms of effectiveness, reliability, and privacy protection. Furthermore, the system was able to detect thalassemia carriers quickly and accurately while also addressing privacy concerns by keeping sensitive health information decentralized.

Conclusion

In conclusion, thalassemia is a serious inherited blood disorder that requires early detection and management. The use of federated learning techniques in identifying beta-thalassemia carriers offers hope for improved outcomes and revolutionizes the screening process. This research presents a promising solution that is quick, accurate, and cost-effective for identifying thalassemia carriers on a large scale. By leveraging SVM classifiers with optimized hyperparameters through federated learning techniques, this study has shown great potential in making a positive impact on managing thalassemia. Early detection and management of thalassemia are crucial in reducing the burden of this condition on individuals, families, and society. The innovative use of federated learning techniques offers a promising solution that can help identify carriers at an early stage and prevent the transmission of thalassemia to future generations. Further research and development in this area could lead to more efficient methods for detecting thalassemia carriers, ultimately improving outcomes for individuals with this inherited blood disorder. With its quick, accurate, and cost-effective approach, this research holds great potential for making a positive impact on managing thalassemia.

Created on 18 Feb. 2024

Assess the quality of the AI-generated content by voting

Score: 0

The previous summary was created more than a year ago and can be re-run (if necessary) by clicking on the Run button below.

Look for similar papers (in beta version)

By clicking on the button above, our algorithm will scan all papers in our database to find the closest based on the contents of the full papers and not just on metadata. Please note that it only works for papers that we have generated summaries for and you can rerun it from time to time to get a more accurate result while our database grows.

Disclaimer: The AI-based summarization tool and virtual assistant provided on this website may not always provide accurate and complete summaries or responses. We encourage you to carefully review and evaluate the generated content to ensure its quality and relevance to your needs.